title: [Iotrolan-300 versus Iopamidol-300 in hysterosalpingography].
abstract: From 9.1988 to 7.1989 we carried out on 50 patients at the Department of Gynaecology of the University of Freiburg a randomized double-blind study to compare the first dimeric, nonionic, hexaiodinated, water-soluble contrast agent (Iotrolan-300 corresponding to Isovist-300) with a nonionic, monomeric preparation (Iopamidol-300 corresponding to Solutrast-300) using the concentration of 300 mg I/ml. Both medicaments show a high contrast quality in the X-rays. Complications like hypersensitivity reactions resp. actual local irritations were not recorded. Iotrolan-300 was found to be the best tolerated of the two contrast media in respect of mildest intensity of pain.
authors.affiliation: Abteilung Gynäkologische Radiologie, Universität Freiburg.
authors.forename: R
authors.initials: R
authors.lastname: Schulz-Wendtland
authors.forename: M
authors.initials: M
authors.lastname: Bauer
authors.forename: K W
authors.initials: KW
authors.lastname: Henne
mesh_terms: D000328:Adult; D003287:Contrast Media; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007047:Hysterosalpingography; D007479:Iopamidol; D014283:Triiodobenzoic Acids
chemical_list: D003287:Contrast Media; D014283:Triiodobenzoic Acids; C033300:iotrolan; D007479:Iopamidol
vernacular_title: Iotrolan-300 versus Iopamidol-300 in der Hysterosalpingographie.